For people with Type 2 diabetes, the MiniMed 780G system—which scored an approval in Europe in July—is currently available with Medtronic’s previous Guardian 4 sensor and will connect to the new ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
NORTHRIDGE, Calif., May 21, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced results from a new randomized crossover study demonstrating that ...
Medtronic has earned FDA approval that will allow it to broaden the scope of its MiniMed 780G system portfolio. FDA has cleared Medtronic’s SmartGuard algorithm as an interoperable automated glycemic ...
Medtronic has launched the MiniMed 780G system in the U.S., integrated with Abbott’s Instinct sensor technology. Medtronic’s integration with Abbott was just approved by FDA in September, broadening ...
BRAMPTON, Ontario, April 28, 2026 (GLOBE NEWSWIRE) -- MiniMed Group, Inc. (MiniMed; Nasdaq: MMED), a global leader in insulin delivery, announced Health Canada has licensed new software for the ...
The FDA has approved Medtronic’s MiniMed 780G automated insulin delivery (AID) system for use in type 2 diabetes (T2D). At the same time, FDA also cleared the MiniMed SmartGuard algorithm as an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results